Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
iLoF
iLoF provides non-invasive biomarker detection and profiling using photonics combined with machine learning to accelerate drug discovery and patient stratification. The company captures optical…
iLoF
iLoF provides non-invasive biomarker detection and profiling using photonics combined with machine learning to accelerate drug discovery and patient stratification. The company captures optical…
TL;DR
Headquarters / HQ: London (operates between UK and Portugal)
Founded: 2020
Technology: AI-powered photonics platform generating optical fingerprints from microlitre blood samples
Primary use cases: Clinical-trial screening, patient stratification, drug discovery
Reported total funding: ≈ $11,480,063 (USD) / reports of a $5M 2022 seed round
Company Overview
Problem Domain
Reduce cost and time of clinical-trial screening and support personalized drug discovery through non-invasive biomarker profiling.
Founded
2020
Industry
Biotechnology Research
Tech Stack
Funding Track Record
$5,000,000
Dealroom reports ~ $5M seed comprising ~$4.1M equity and a ~€900k regional grant; participation from M12, Quiet Capital, Lunar Ventures noted.
€200,000 (reported)
Reported small investment via a simple agreement for future equity.
Investor Signal
“Includes corporate and institutional investors such as Hamamatsu Ventures, M12 (Microsoft's fund), Luminate, Faber, Quiet Capital, Lunar Ventures and several grants/European innovation funds.”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |